Chemo-informatics applications in the design of novel 7-keto-sempervirol derivatives as SmCB1 inhibitors with potential for treatment of Schistosomiasis

Chemo-informatics applications in the design of novel 7-keto-sempervirol derivatives as SmCB1 inhibitors with potential for treatment of Schistosomiasis

The quest for a sound treatment on the vulnerable population suffering and dying as a result of the blood flukes, S. mansoni is on the increase because both Praziquantel and Oxamniquine widely used for the treatment of Schistosomiasis for over 51 years suffer resistance and recurrence. Here-in, chem...

Full description

Bibliographic Details
Main Authors:	Salim Bitrus Anyubaga, Gideon Adamu Shallangwa, Adamu Uzairu, Stephen Eyije Abechi
Format:	Article
Language:	English
Published:	Elsevier 2024-01-01
Series:	Heliyon
Subjects:	Schistosomiasis Blood flukes QSAR Docking-simulation Pharmacokinetics MD simulation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844023103239

Similar Items

Quantitative Structure-Activity Relationship, Structure-based Design, and ADMET studies of pyrimethamine and cycloguanil analogs inhibitors of Plasmodium falciparum dihydrofolate reductase-thymidylate synthase (PfDHFR-TS).
by: Zakari Ya'u Ibrahim, et al.
Published: (2022-12-01)

2D-QSAR, Docking, Molecular dynamics simulations with the MM/GBSA approaches against Grave's disease and PTPN22
by: Emmanuel Israel Edache, et al.
Published: (2023-08-01)

A novel QSAR model for designing, evaluating,and predicting the anti-MES activity of new 1H-pyrazole-5-carboxylic acid derivatives
by: Adedirin Oluwaseye, et al.
Published: (2017-07-01)

Pharmacokinetic predictions and docking studies of substituted aryl amine-based triazolopyrimidine designed inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH)
by: Zakari Ya’u Ibrahim, et al.
Published: (2021-07-01)

QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent
by: Abduljelil Ajala, et al.
Published: (2023-01-01)

2D QSAR, design, docking study and ADMET of some N-aryl derivatives concerning inhibitory activity against Alzheimer disease
by: Abduljelil Ajala, et al.
Published: (2022-06-01)

Theoretical design of novel antimalarial agents against P. falciparum strain, Dd2 through the QSAR modeling of synthesized 2′-substituted triclosan derivatives
by: Zakari Ya'u Ibrahim, et al.
Published: (2020-09-01)

Virtual screening and molecular dynamic simulations of the antimalarial derivatives of 2-anilino 4-amino substituted quinazolines docked against a Pf-DHODH protein target
by: Zakari Ya’u Ibrahim, et al.
Published: (2022-08-01)

Computer-aided identification of a series of novel ligands showing high potency as hepatitis C virus NS3/4A protease inhibitors
by: Stephen Ejeh, et al.
Published: (2021-01-01)

COMPUTATIONAL STUDIES OF SOME BISCOUMARIN AND BISCOUMARIN THIOUREA DERIVATIVES AS ⍺-GLUCOSIDASE INHIBITORS
by: Muhammad Tukur Ibrahim, et al.
Published: (2018-07-01)

Profiling the antidepressant properties of phenyl piperidine derivatives as inhibitors of serotonin transporter (SERT) via cheminformatics modeling, molecular docking and ADMET predictions.
by: Sabitu Babatunde Olasupo, et al.
Published: (2020-09-01)

Development of Predictive Antioxidant Models for 1,3,4-Oxadiazoles by Quantitative Structure Activity Relationship
by: Ikechukwu Alisi, et al.
Published: (2019-06-01)

QSAR and molecular docking based design of some indolyl-3-ethanone-α-thioethers derivatives as Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors
by: Zakari Ya’u Ibrahim, et al.
Published: (2020-06-01)

Quantitative structure-activity relationship, molecular docking, drug-likeness, and pharmacokinetic studies of some non-small cell lung cancer therapeutic agents
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-12-01)

Computer-aided drug design and in silico pharmacokinetics predictions of some potential antipsychotic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2021-07-01)

Structure-based design and activity modeling of novel epidermal growth factor receptor kinase inhibitors; an in silico approach
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-09-01)

QSAR, Docking, and Molecular Dynamics Simulation Studies of Sigmacidins as Antimicrobials against <i>Streptococci</i>
by: Jiqing Ye, et al.
Published: (2022-04-01)

QSAR and molecular docking studies of 1,3-dioxoisoindoline-4-aminoquinolines as potent antiplasmodium hybrid compounds
by: Aliyu Wappah Mahmud, et al.
Published: (2020-03-01)

Theoretical activity prediction, structure-based design, molecular docking and pharmacokinetic studies of some maleimides against Leishmania donovani for the treatment of leishmaniasis
by: Fabian Audu Ugbe, et al.
Published: (2022-04-01)

Computational modeling of novel quinazoline derivatives as potent epidermal growth factor receptor inhibitors
by: Muhammad Tukur Ibrahim, et al.
Published: (2020-02-01)

Computational and pharmacokinetics studies of 1,3-dimethylbenzimidazolinone analogues of new proposed agent against Alzheimer's disease
by: Abduljelil Ajala, et al.
Published: (2022-04-01)

In silico studies of 2,5-disubstituted furans as active antimalarial drug candidates
by: Aliyu Wappah Mahmud, et al.
Published: (2020-05-01)

In silico modeling of tetraoxane-8-aminoquinoline hybrids active against Plasmodium falciparum
by: Aliyu Wappah Mahmud, et al.
Published: (2020-06-01)

Computational modelling of some anti-friction lubricant additives
by: Usman Abdulfatai, et al.
Published: (2020-04-01)

Chemoinformatic studies on some inhibitors of dopamine transporter and the receptor targeting schizophrenia for developing novel antipsychotic agents
by: Sabitu Babatunde Olasupo, et al.
Published: (2020-07-01)

Quantitative Structure-Activity Relationship (QSAR) Studies and Molecular docking Simulation of Norepinephrine Transporter (NET) Inhibitors as Anti-psychotic Therapeutic Agents
by: Sabitu Babatunde OLASUPO, et al.
Published: (2020-02-01)

Computational assessment of the reactivity and pharmaceutical potential of novel triazole derivatives: An approach combining DFT calculations, molecular dynamics simulations, and molecular docking
by: Kamal Tabti, et al.
Published: (2024-01-01)

Comparison of the binding energies of approved mpox drugs and phytochemicals through molecular docking, molecular dynamics simulation, and ADMET studies: An in silico approach
by: Ranjan K. Mohapatra, et al.
Published: (2023-09-01)

In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators
by: Magdi E. A. Zaki, et al.
Published: (2023-04-01)

<i>In Silico</i> Strategies in Tuberculosis Drug Discovery
by: Stephani Joy Y. Macalino, et al.
Published: (2020-02-01)

Chemical bioinformatics study of Nonadec-7-ene-4-carboxylic acid derivatives via molecular docking, and molecular dynamic simulations to identify novel lead inhibitors of hepatitis c virus NS3/4a protease
by: Stephen Ejeh, et al.
Published: (2023-07-01)

Quantitative structure-properties relationship and molecular design of some anti-wear lubricant additives
by: Usman Abdulfatai, et al.
Published: (2020-10-01)

A combined 2-D and 3-D QSAR modeling, molecular docking study, design, and pharmacokinetic profiling of some arylimidamide-azole hybrids as superior L. donovani inhibitors
by: Fabian Audu Ugbe, et al.
Published: (2022-06-01)

INSILICO MODELLING ON SOME C14-UREA TETRANDRINE COMPOUNDS AS POTENT ANTI-CANCER AGAINST HUMAN ERYTHROLEUKEMIA (HEL) CELL LINE
by: Mustapha Abdullahi, et al.
Published: (2019-03-01)

IN-SILICO STUDY FOR PREDICTING THE INHIBITION CONCENTRATION OF SOME HETEROCYCLIC AND PHENYLIC COMPOUNDS AS POTENT HERBICIDES USING THE MLR - GFA APPROACH
by: SAIDU TUKUR, et al.
Published: (2019-03-01)

Molecular modeling and design of some β-amino alcohol grafted 1,4,5-trisubstituted 1,2,3-triazoles derivatives against chloroquine sensitive, 3D7 strain of Plasmodium falciparum
by: Zakari Ya'u Ibrahim, et al.
Published: (2021-01-01)

QSAR modelling and molecular docking studies for anti-cancer compounds against melanoma cell line SK-MEL-2
by: Abdullahi Bello Umar, et al.
Published: (2020-03-01)

In silico screening, pharmacokinetic, DFT, and dynamics simulation study of ant-hepatitis C virus compounds as potential NS5B Polymerase inhibitors
by: Stephen Ejeh, et al.
Published: (2024-03-01)

IN SILICO MODELLING OF CYTOTOXIC BEHAVIOUR OF ANTI-LEUKEMIC COMPOUNDS ON HL-60 CELL LINE
by: David Ebuka Arthur, et al.
Published: (2016-05-01)

Ligand-based drug design and molecular docking simulation studies of some novel anticancer compounds on MALME-3M melanoma cell line
by: Abdullahi Bello Umar, et al.
Published: (2021-01-01)